INTERACTIONS Spurdle et al
I appreciate you writing this article plus the rest of the website is very good
Never share pens between patients, even if the needle is changed
Some women report missed periods or irregular cycles after missed doses, especially during early weight loss phases
Important considerations for ongoing treatment: Regular review with the prescribing healthcare professional is essential Treatment should be discontinued if no clear benefit is observed after an adequate trial period (typically 812 weeks) Do not delay seeking medical attention for new or worsening symptoms Be alert to red flag symptoms requiring urgent assessment, such as unexplained weight loss, persistent fever, chest pain, or suicidal thoughts Patients should maintain realistic expectations , recognising that robust evidence for clinical benefits remains limited
Understanding the evidence, risk factors, and contraindications helps patients and providers make informed treatment decisions